van der Schaaf I C, Wermer M J H, Velthuis B K, Buskens E, Bossuyt P M M, Rinkel G J E
Department of Radiology E01.132, University Medical Centre Utrecht, PO Box 85500, 3508 GA Utrecht, Netherlands.
J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):748-52. doi: 10.1136/jnnp.2005.079194.
In patients with previous subarachnoid haemorrhage (SAH) undergoing follow up screening, the authors assessed the impact of finding but not treating very small aneurysms by comparing quality of life (QOL), anxiety, and depression between patients with a newly detected aneurysm that was left untreated (cases) and patients with a negative screening (controls) as this should be incorporated in the evaluation of effectiveness of screening.
In patients with previous SAH undergoing screening for new aneurysms the authors compared QOL (SF-36, EURO-QOL, and a screening related questionnaire), anxiety, and depression (Hospital Anxiety and Depression Scale (HADS)) between cases and controls. Differences in scores on the SF-36, EURO-QOL, and HADS were assessed with Student's t test and differences in proportions of patients with HADS scores in the pathological range and screening related changes with chi2 analysis. The authors powered the study to detect a moderate, clinically relevant difference.
Thirty five cases and 34 controls were included. Trends for health related QOL, anxiety, depression, and consequences in daily life pointed in the same direction of a less favourable situation for cases but all effects were small, and did not reach statistical significance. On the screenings specific questionnaire, cases more often (but not statistically significant) reported changes in daily life.
The authors found no major or moderate impact on QOL, anxiety, and depression of the awareness of having an untreated aneurysm, which was detected at screening, although most items showed a trend towards more negative effects for cases. Minor effects on individual level cannot be excluded by this study.
在接受随访筛查的既往蛛网膜下腔出血(SAH)患者中,作者通过比较未治疗的新发现动脉瘤患者(病例组)和筛查阴性患者(对照组)的生活质量(QOL)、焦虑和抑郁情况,评估发现但未治疗非常小的动脉瘤的影响,因为这应纳入筛查有效性评估中。
在接受新动脉瘤筛查的既往SAH患者中,作者比较了病例组和对照组的QOL(SF-36、欧洲生活质量量表(EURO-QOL)和一份与筛查相关的问卷)、焦虑和抑郁(医院焦虑抑郁量表(HADS))。使用学生t检验评估SF-36、EURO-QOL和HADS评分的差异,使用卡方分析评估HADS评分处于病理范围的患者比例差异以及与筛查相关的变化。作者为该研究设定了检测中等程度、具有临床相关性差异的效能。
纳入了35例病例和34例对照。与健康相关的QOL、焦虑、抑郁及日常生活后果的趋势表明病例组情况较差,但所有影响都较小,未达到统计学显著性。在筛查特定问卷上,病例组更常(但无统计学显著性)报告日常生活有变化。
作者发现,筛查时发现有未治疗的动脉瘤这一情况,对QOL、焦虑和抑郁没有重大或中等程度的影响,尽管大多数项目显示病例组有更负面影响的趋势。本研究不能排除对个体层面有轻微影响。